Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,714 across all filing types
Latest filing 2020-11-12 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于独立董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director from the company's board. It details the director's resignation, the impact on board composition, and the process for appointing a new director. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting or voting results. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-11-12 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report". It details the change in shareholding of 清华控股有限公司 (Tsinghua Holdings Co., Ltd.) in 启迪古汉集团股份有限公司 (Qidi Guhan Group Co., Ltd.). The document includes detailed information about the shareholding changes, the purpose of the equity change, the transaction agreement, approvals required, and the impact on control of the company. It also references relevant laws and regulations such as the Company Law, Securities Law, and the Listing Company Acquisition Management Measures. The document is a formal disclosure of a significant change in share ownership, consistent with a Major Shareholding Notification. It is not an annual report, earnings release, or any other type of report. It is a regulatory disclosure about a change in significant share ownership, fitting the category of Major Shareholding Notification (MRQ). The document length is over 10,000 characters and contains substantive content, not just an announcement or certification, so it is not RPA or RNS.
2020-11-05 Chinese
关于间接控股股东股份变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a change in shareholding structure involving indirect controlling shareholders. It details the transfer of shares between two companies, the impact on control, and the regulatory approval process. The text includes specific information about the parties involved, share quantities, and the transaction contract. It is not a full financial report, earnings release, or management discussion. It is a formal disclosure of a significant shareholding change, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a report or announcement of a report publication.
2020-11-05 Chinese
关于使用部分闲置自有资金继续进行理财管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using part of its idle funds for financial management, specifically investing in low-risk financial products such as bank deposits and structured deposits. It details the amounts, types of investments, risk control measures, and approvals by the board and supervisory committee. The document does not contain financial statements or detailed financial results but is a regulatory disclosure about capital management activities. It is not an annual or interim report, earnings release, or audit report. It is an update on capital/financing activities related to the use of company funds for financial management. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is short (2112 characters), but it contains substantive information about capital use, not just a report publication announcement or a simple regulatory filing. Confidence is high due to clear content matching the CAP category.
2020-11-04 Chinese
关于使用部分闲置募集资金购买的理财产品到期赎回并继续进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the redemption of financial products purchased with idle raised funds and the continuation of cash management activities. It details specific transactions, amounts, dates, and risk control measures related to the use of idle raised funds for purchasing financial products such as bank deposits and wealth management products. The document does not contain comprehensive financial statements or detailed financial performance data. Instead, it reports on the progress and status of specific financial management activities related to raised funds. The document length is 4715 characters, which is relatively short and focused on a specific financing/capital management update. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2020-10-30 Chinese
2020年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2020 Third Quarter Report" of 启迪古汉集团股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2020. The presence of actual financial statements and substantive financial data confirms it is a comprehensive interim report rather than a brief announcement or a certification. The document length is substantial (15,000 characters), and it includes management's discussion of financial results and operational highlights for the quarter. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-10-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.